Press releaseGlobe Newswire
Aptorum Group
NIKI · NASDAQ
$1.83−$0.03 (−1.61%)TodayMarket closed ·
Prev close $1.86
Latest news
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
Niki BioSolutions’ Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation’s “Rett Research Tool Belt” Series
- Press releaseGlobe Newswire
Niki BioSolutions Partners with Global Alzheimer’s Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002
- Press releaseGlobe Newswire
Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference
- Press releaseGlobe Newswire
Niki BioSolutions Accelerates Its Alzheimer’s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics
- Press releaseGlobe Newswire
Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.